The North America & Europe Diabetic Footwear Market, valued at US$ 4.12 Bn in 2022, is anticipated to reach US$ 7.44 Bn by 2031, growing at a CAGR of 7.09%. The volume of the market stood at 82.38 million units in 2022, underscoring the significant demand for diabetic footwear in these regions.North America & Europe Diabetic Footwear Market: Projected to Reach US$ 7.44 Bn by 2031
Growth Influencers:
The market's growth is primarily driven by the increasing prevalence of diabetes, necessitating specialized footwear to prevent foot-related complications. However, the high cost associated with diabetic footwear and foot ulcer treatment challenges market expansion.Segment Overview:
The market is segmented into types such as shoes, slippers, sandals, and socks, with shoes leading in revenue generation. By end-user, women represent the largest segment, while men and kids also contribute significantly. The distribution channels are bifurcated into offline and online, with offline channels expected to surpass US$ 4.1 Bn by 2031.By Type
- Slippers
- Sandals
- Shoes
- Socks
By End User
- Men
- Women
- Kids
By Distribution Channel
- Offline
- Online
Regional Overview:
North America leads the market, holding over 55% share in 2022, followed by Europe. Within Europe, countries like the UK, Germany, France, Italy, and Spain are key contributors to the market.By Region
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Poland
- Russia
- Rest of Europe
Competitive Landscape:
Key players include Aetrex Worldwide Inc., Apis Footwear Company, DARCO Medical India, and others, collectively holding nearly 40% market share. These companies significantly influence market dynamics through their product offerings and innovations.Report Insights:
- The diabetic footwear market in North America and Europe is on a growth trajectory, expected to reach US$ 7.44 Bn by 2031.
- Women emerge as the largest end-user segment, indicating a focused market demand.
- Offline distribution channels dominate, but online channels are gaining traction.
Questions to be Answered:
- What is the projected growth of the diabetic footwear market in North America and Europe by 2031?
- Which are the leading segments in the diabetic footwear market?
- How do different regions within North America and Europe contribute to the market?
- What role do major companies play in shaping the market dynamics?
Table of Contents
Chapter 1. Research Framework
Chapter 2. Research Methodology
Chapter 4. North America & Europe Diabetic Footwear Market Overview
Chapter 5. North America & Europe Diabetic Footwear Market Analysis, By Type
Chapter 6. North America & Europe Diabetic Footwear Market Analysis, By End User
Chapter 7. North America & Europe Diabetic Footwear Market Analysis, By Distribution Channel
Chapter 8. North America & Europe Diabetic Footwear Market Analysis, By Region
Chapter 9. North America Diabetic Footwear Market Analysis
Chapter 10. Europe Diabetic Footwear Market Analysis
Chapter 11. The U.S. Diabetic Footwear Market Analysis
Chapter 22. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aetrex Worldwide Inc.
- Apis Footwear Company
- DARCO Medical India
- Dr. Brinsley
- Dr. Comfort
- Drew Shoe
- Hochste Healthcare Private Limited
- Medical Expo
- Sun Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 206 |
| Published | November 2023 |
| Forecast Period | 2022 - 2031 |
| Estimated Market Value ( USD | $ 4.12 Billion |
| Forecasted Market Value ( USD | $ 7.44 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Europe, North America |
